Clinical trials
Withdrawn Phase 2 trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 2 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 1 |
| Boston Scientific Corporation | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| GlaxoSmithKline | 1 |
| Haukeland University Hospital | 1 |
| Norwegian Underwater Intervention (NUI) | 1 |
| Sangart | 1 |
| Sykehuset Telemark | 1 |
| Ullevaal University Hospital | 1 |
| University Hospital of North Norway | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 2 |
| Acidosis, Lactic | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Atherosclerosis | 1 |
| Breast Neoplasms | 1 |
| Diabetic Nephropathies | 1 |
| Headache | 1 |
| Hemochromatosis | 1 |
| Hemorrhage | 1 |
| Infertility | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.